gebhart/patrepeval huggingface dataset:
Peptide exchange in MHC molecules (1999)

Major histocompatibility complex (MHC)-encoded glycoproteins bind peptide antigens through non-covalent interactions to generate complexes that are displayed on the surface of antigen-presenting cells (APC) for recognition by T cells. Peptide-binding site occupancy is necessary for stable assembly of newly synthesized MHC proteins and export from the endoplasmic reticulum (ER). The MHC class II antigen-processing pathway provides a mechanism for presentation of peptides generated in the endosomal pathway of APC. The chaperone protein, invariant chain, includes a surrogate peptide that stabilizes newly synthesized class II molecules during transport to endosomal compartments. The invariant chain-derived peptide must be replaced through a peptide exchange reaction that is promoted by acidic pH and the MHC-encoded co-factor HLA-DM. Peptide exchange reactions are not required for presentation of antigens by MHC class I molecules because they bind antigens during initial assembly in the ER. However, exchange reactions may play an important role in editing the repertoire of peptides presented by both class II and class I molecules, thus influencing the specificity of immunity and tolerance.
Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. (2002)

Morphine is used to treat pain in several medical conditions including cancer. Here we show that morphine, in a concentration typical of that observed in patients' blood, stimulates human microvascular endothelial cell proliferation and angiogenesis in vitro and in vivo. It does so by activating mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation via Gi/Go-coupled G protein receptors and nitric oxide in these microvascular endothelial cells. Other contributing effects of morphine include activation of the survival signal PKB/Akt, inhibition of apoptosis, and promotion of cell cycle progression by increasing cyclin D1. Consistent with these effects, morphine in clinically relevant doses promotes tumor neovascularization in a human breast tumor xenograft model in mice leading to increased tumor progression. These results indicate that clinical use of morphine could potentially be harmful in patients with angiogenesis-dependent cancers.
Characterization of the Effect of Insulin on Collagen Synthesis in Fetal Rat Bone* (1985)

We characterized the effect of insulin on collagen synthesis in 21-day-old fetal rat calvaria maintained in organ culture. All experiments were done in the presence of 100 mg/dl glucose and 3 mM phosphate, which were found to be optimal concentrations for insulin responsiveness. All concentrations of insulin tested (1 nM to 1 microM) increased the percentage of collagen being synthesized in the central bone, whereas only high concentrations of hormone (100 nM to 1 microM) increased the percentage of collagen being synthesized in periosteum. Insulin at 3 nM increased the labeling of type I collagen in the central bone, but did not alter the labeling of type I or III collagen in the periosteum. Proinsulin was approximately 10-100 times less effective than insulin in stimulating collagen synthesis, whereas porcine relaxin and C-peptide were ineffective. Insulin did not enhance the deposition of newly synthesized collagen in the bone by a mechanism that involved decreasing the degradation of collagen. To determine whether insulin enhanced collagen synthesis by increasing the replication of collagen-synthesizing cells, we tested the effect of insulin in the presence of hydroxyurea, a DNA synthesis inhibitor. Hydroxyurea at 1 mM had little effect on collagen synthesis in control cultures or those treated with 1 or 10 nM insulin. However, hydroxyurea blunted the stimulation of collagen synthesis that occurred at higher concentrations of insulin. These experiments suggest that insulin at physiological levels appears to increase bone collagen synthesis by a direct effect on the osteoblast, whereas insulin at high concentrations has an additional action to increase the replication of collagen-synthesizing cells.
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome (2014)

The distinction between acquired aplastic anemia (AA) and hypocellular myelodysplastic syndrome (hMDS) is often difficult, especially nonsevere AA. We postulated that somatic mutations are present in a subset of AA, and predict malignant transformation. From our database, we identified 150 AA patients with no morphological evidence of MDS, who had stored bone marrow (BM) and constitutional DNA. We excluded Fanconi anemia, mutations of telomere maintenance, and a family history of BM failure (BMF) or cancer. The initial cohort of 57 patients was screened for 835 known genes associated with BMF and myeloid cancer; a second cohort of 93 patients was screened for mutations in ASXL1, DNMT3A, BCOR, TET2, and MPL. Somatic mutations were detected in 19% of AA, and included ASXL1 (n = 12), DNMT3A (n = 8) and BCOR (n = 6). Patients with somatic mutations had a longer disease duration (37 vs 8 months, P < .04), and shorter telomere lengths (median length, 0.9 vs 1.1, P < .001), compared with patients without mutations. Somatic mutations in AA patients with a disease duration of >6 months were associated with a 40% risk of transformation to MDS (P < .0002). Nearly one-fifth of AA patients harbor mutations in genes typically seen in myeloid malignancies that predicted for later transformation to MDS.
Light as a potential treatment for pandemic coronavirus infections: A perspective (2020)

The recent outbreak of COVID-19, which continues to ravage communities with high death tolls and untold psychosocial and catastrophic economic consequences, is a vivid reminder of nature's capacity to defy contemporary healthcare. The pandemic calls for rapid mobilization of every potential clinical tool, including phototherapy-one of the most effective treatments used to reduce the impact of the 1918 "Spanish influenza" pandemic. This paper cites several studies showing that phototherapy has immense potential to reduce the impact of coronavirus diseases, and offers suggested ways that the healthcare industry can integrate modern light technologies in the fight against COVID-19 and other infections. The evidence shows that violet/blue (400-470 nm) light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen's Nobel-winning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma. These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder. The ubiquity of inexpensive light emitting lasers and light emitting diodes (LEDs), makes it relatively easy to develop safe low-cost light-based devices with the potential to reduce infections, sanitize equipment, hospital facilities, emergency care vehicles, homes, and the general environment as pilot studies have shown.
Using Life-Story Research in Gifted Education (2009)

In this article I discuss a promising approach to the problem of gifted underachievement, the research tradition of life story, and I examine the nature of constructed narratives and explain the narrative methods used to conduct this study. I include portions of one constructed narrative to illustrate the narrative product of life story research.
Electrolytic Tritium Production (1990)

Fifty-three electrolytic cells of various configurations and electrode compositions were examined for tritium production. Significant tritium was found in 11 cells at levels between 1.5 and 80 times the starting concentration after enrichment corrections are made.
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals (1997)

Recent studies have identified several coreceptors that are required for fusion and entry of Human Immunodeficiency Virus type 1 (HIV-1) into CD4+ cells. One of these receptors, CCR5, serves as a coreceptor for nonsyncytium inducing (NSI), macrophage-tropic strains of HIV-1, while another, fusin or CXCR-4, functions as a coreceptor for T cell line-adapted, syncytium-inducing (SI) strains. Using sequential primary isolates of HIV-1, we examined whether viruses using these coreceptors emerge in vivo and whether changes in coreceptor use are associated with disease progression. We found that isolates of HIV-1 from early in the course of infection predominantly used CCR5 for infection. However, in patients with disease progression, the virus expanded its coreceptor use to include CCR5, CCR3, CCR2b, and CXCR-4. Use of CXCR-4 as a coreceptor was only seen with primary viruses having an SI phenotype and was restricted by the env gene of the virus. The emergence of variants using this coreceptor was associated with a switch from NSI to SI phenotype, loss of sensitivity to chemokines, and decreasing CD4+ T cell counts. These results suggest that HIV-1 evolves during the course of infection to use an expanded range of coreceptors for infection, and that this adaptation is associated with progression to AIDS.
Dermatological And Transdermal Formulations (2002)

The structure and function of the skin common skin disorders and their topical treatment basic mathematical principles in skin permeation skin transport methods for studying percutaneous absorption formulation strategies for modulating skinpermeation formulation and development of dermatological dosage forms bioequivalence of dermal and transdermal formulations scale-up of dermatological dosage forms a case for multivariate optimization and product homogeneity transdermal drug deliverysystems safety considerations for dermal and transdermal products transdermal delivery and cutaneous reactions.
2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells. (1992)

BHK cells blocked at any of several points in the cell cycle override their drug-induced arrest and proceed in the cycle when exposed concurrently to the protein kinase inhibitor 2-aminopurine (2-AP). For cells arrested at various points in interphase, 2-AP-induced cell cycle progression is made evident by arrival of the drug-treated cell population in mitosis. Cells that have escaped from mimosine G1 arrest, from hydroxyurea or aphidicolin S-phase arrest, or from VM-26-induced G2 arrest subsequently have all the hallmarks of mitosis--such as a mitotic microtubule array, nuclear envelope breakdown, and chromatin condensation. In a synchronous population, the time course of arrival in mitosis and its duration in 2-AP-treated cells that have escaped drug-induced cell cycle blocks is indistinguishable from control cells. Cells arrested in mitosis by nocodazole or taxol quickly escape mitotic arrest and enter interphase when exposed to 2-AP. 2-AP by itself does not influence the timing of cell cycle progression. We conclude that 2-AP acts to override checkpoints in every phase of the cell cycle, perhaps by inhibiting a protein kinase responsible for control of multiple cell cycle checkpoints.
Histopathological and serological progression of experimental Staphylococcus aureus arthritis (1992)

In a newly developed mouse model of Staphylococcus aureus arthritis the kinetics of joint destruction and serological manifestations as well as the clinical course of arthritis and osteitis were studied. Almost all mice developed histopathological signs of arthritis upon a single intravenous injection of 10(7) S. aureus LS-1 cells. There was rapid joint destruction, with synovial hypertrophy already visible, within 24 h after injection of the bacteria. Cartilage and/or bone erosions were seen in a majority of the mice within 72 h. Extra-articular manifestations, especially signs of bone infection, were also found soon after inoculation of the bacteria. Tail osteitis was frequent (50% of the mice) but appeared later than arthritis. Polymorphonuclear cells prevailed in the early joint lesions and were also common in the extra-articular manifestations. Within 3 days, mononuclear cells were also seen in the inflamed synovium, gaining a dominant position 3 weeks after the start of the disease. Serum interleukin-6 levels were already increased within 6 h after bacterial injection and remained elevated throughout the course of arthritis. Serum tumor necrosis factor levels were increased within 24 h. There was a tremendous induction of immunoglobulin production, especially of the immunoglobulin G1 isotype. This was paralleled by the production of specific antibodies to S. aureus (cell walls and toxin), as well as autoantibodies (rheumatoid factors and anti-single-stranded DNA antibodies), all predominantly of the immunoglobulin G isotype. The type and magnitude of the immunoglobulin G response together with the elevated interleukin-6 levels speak in favor of both antigen-specific and polyclonal B-cell activation during S. aureus arthritis. This study points out important similarities between our new model of S. aureus arthritis and human S. aureus arthritis. This resemblance will enable controlled studies of pathogenetic mechanisms of septic arthritis as well as therapeutic and prophylactic approaches.
Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. (1995)

Current imaging modalities used to stage prostate cancer clinically fail to detect extracapsular disease in a significant subset of patients. A molecular based peripheral blood assay using the reverse transcriptase polymerase chain reaction has recently been shown to be a highly sensitive staging modality for detecting extraprostatic disease preoperatively. The assay uses primers that are specific for prostate specific antigen (PSA). We compare the application of the reverse transcriptase polymerase chain reaction assay using primers specific for the human prostate specific membrane antigen with results obtained from the same specimens by reverse transcriptase polymerase chain reaction for PSA. Prostate specific membrane antigen, a recently cloned prostatic antigen, is a transmembrane glycoprotein that has been described as prostate specific. These assays were applied to ribonucleic acids extracted from the peripheral blood lymphocyte fraction of 80 patients with clinically localized prostate cancer. In addition, blood specimens from 20 female patients, 20 young male patients, 25 age-matched control men under treatment for benign prostatic hypertrophy and 20 men with established, untreated metastatic prostate cancer were tested. All 3 groups of noncancer patients had negative polymerase chain reactions for PSA as well as prostate specific membrane antigen. Of 20 metastatic prostate cancer patients 16 (80%) had positive polymerase chain reactions for PSA, while only 10 (50%) had positive results for prostate specific membrane antigen. Among the 80 patients with clinically localized disease (stages T1 to T2cN0M0), 27 and 19 had positive polymerase chain reaction for PSA and prostate specific membrane antigen, respectively, from blood specimens obtained preoperatively. Analyzing the final pathology in each patient with the reverse transcriptase polymerase chain reaction assay identified a significantly stronger correlation with tumor invasion using the results of the PSA test rather than the results of the prostate specific membrane antigen reverse transcriptase polymerase chain reaction test (67% versus 34% sensitivity for detecting capsular penetration, 87% versus 46% sensitivity for detecting disease to the surgical margin and 83% versus 16% sensitivity for detecting seminal vesicle invasion). In contrast to the reverse transcriptase polymerase chain reaction assay for PSA, a similar assay done for prostate specific membrane antigen did not correlate with pathological stage of prostate cancer.
Nephron‐sparing surgery for renal tumours using selective renal parenchymal clamping (2005)

Selective renal parenchymal clamping is a simple and efficient technical manoeuvre that facilitates NSS without dissection or clamping of the renal pedicle. Time is not limited as the ischaemia is limited to the tissue surrounding the tumour. The operative duration and blood loss are acceptable and the complications similar to those with the conventional technique. The size and position of the tumour could be limiting factors to this technique.
Resectoscope with an easy to use twist mechanism for improved handling (2016)

Abstract One of the oldest methods used in minimally invasive surgeries is the transurethral resection. This is an operation technique in which diseased tissue from the bladder or the prostate is removed using a resectoscope through the urethra [Schostak M, Blana A, Hrsg. Alternative operative Therapien in der Uroonkologie. Berlin, Heidelberg, Springer Berlin Heidelberg; 2016]. A resectoscope has a channel for the view of the surgeon, a liquid supply, a working channel and a hand piece which could rotate up to 360 degrees. A RF- electrode on the tip of the resectoscope is used to cut out pathological growths. For diseased tissue which is located in the bladder on the ventral side, a rotation of the resectoscope up to 180 degrees is necessary. This means on the one side tiring of the hands, wrist pain and a change of the position of the operating surgeon. On the other side a reorganization of the connected tubes and cables is necessary. To avoid these problems and integrate additional features a standard resectoscope was adapted with an easy to use twist mechanism. After discussion with experienced urological surgeons a complete new design of the resectoscope with a twist mechanism in combination with a gyro sensor and a reference display was realized.
Extracellular ATP in the Immune System: More Than Just a “Danger Signal” (2009)

Extracellular adenosine 5'-triphosphate (eATP) is ubiquitously used for cell-to-cell communication. The low concentration of eATP ([eATP]) that exists in a "halo" surrounding resting cells signals the presence of neighboring living cells. Transient increases in [eATP] are used for basic physiological signaling, namely, in the nervous and vascular systems. Larger increases in [eATP] that are associated with cell death serve as a key "danger" signal in inflammatory processes. Two studies now point to roles for ATP in the immune system: providing a costimulatory signal to T cells and driving the differentiation of intestinal T helper 17 (T(H)17) cells.
A multi-mode fiber probe for holographic micromanipulation and microscopy (2011)

Holographic tweezers have revolutionized the way we do experiments at the micron scale. The possibility of applying controlled force fields on simultaneously trapped micro-particles has allowed to directly probe interactions and mechanical properties of colloids, macromolecules and living cells. Holographic micromanipulation requires the careful shaping of a laser beam that is then focused by a microscope objective onto a micro-hologram in the sample volume. The same objective is used for imaging. That approach is therefore limited to in vitro samples contained in transparent cells that are easily accessed optically. Here we demonstrate that the complex light propagator of a real multimode fiber can be directly measured. That allows to transmit a micro-hologram through a 1 metre long (60 μm core) optical fiber and produce dynamic arrays of focused spots at the fiber output. We show that those spots can be used for interactive holographic micromanipulation of micron sized beads facing the fiber tip. Scanning a single spot across the output fiber we can employ the same fiber as a probe for scanning fluorescence microscopy. Our findings open the way towards the fabrication of endoscopic probes which could be capable of seeing and manipulating single cells deep into biological tissues.
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target (2013)

Human carcinomas frequently exhibit significant stromal reactions such as the so-called "desmoplastic stroma" or "reactive stroma", which is characterised by the existence of large numbers of stromal cells and extracellular matrix proteins. Carcinoma-associated fibroblasts (CAFs), which are rich in activated fibroblast populations exemplified by myofibroblasts, are among the predominant cell types present within the tumour-associated stroma. Increased numbers of stromal myofibroblasts are often associated with high-grade malignancies with poor prognoses in humans. CAF myofibroblasts possess abilities to promote primary tumour development, growth and progression by stimulating the processes of neoangiogenesis as well as tumour cell proliferation, survival, migration and invasion. Moreover, it has been demonstrated that CAFs serve as a niche supporting the metastatic colonisation of disseminated carcinoma cells in distant organs. Their contribution to primary and secondary malignancies makes these fibroblasts a potential therapeutic target and they also appear to be relevant to the development of drug resistance and tumour recurrence. This review summarises our current knowledge of tumour-promoting CAFs and discusses the therapeutic feasibility of targeting these cells as well as disrupting heterotypic interactions with other cell types in tumours that may improve the efficacy of current anti-tumour therapies.
Treatment of hepatitis B virus (HBV) in the setting of HIV-HBV co-infection (2009)

Liver disease in individuals with HIV-HBV co-infection is now a major cause of mortality worldwide, including Asia. The pathogenesis of liver disease in this setting is multifactorial, but includes drug toxicity and immunological factors, such as immune restoration disease. Staging of chronic hepatitis B is important prior to commencement of anti-retroviral therapy and should include quantification of HBV DNA, and, where possible, an assessment of liver fibrosis, either by liver biopsy or non-invasive measurement. Earlier treatment of both HIV and HBV is now generally advocated, and treatment is usually life-long.
Phenotypic Characterization of Lettuce Dwarf Mutants and Their Response to Applied Gibberellins (1991)

Four monogenic, recessive dwarf mutants of lettuce (Lactuca sativa L.), previously isolated from a population induced by ethyl methanesulfonate, were compared with the normal genotype (E-1) for plant height, weight, leaf area, as well as hypocotyl length and root length. These nonallelic dwarfs (dwf1, dwf2, and dwf3) exhibited reduced hypocotyl length, smaller, dark green leaves, and reduced stem length. Another mutant, dwf2, allelic with dwf2, exhibited an intermediate phenotype. Epidermal cells on hypocotyls and mature leaves were counted for both normal E-1 and dwf2 plants. The total number of epidermal cells per unit area for hypocotyls and for leaves from these plants was very similar, implying the dwarf's smaller size was due to an inhibition of cell expansion and not due to decreased cell divisions. Both dwarf and normal hypocotyls elongated normally in response to exogenous gibberellin A(3) (GA(3)). In the rosette stage, only E-1 and dwf2 responded similarly to lower concentrations of GA(3), while the other dwarfs required higher concentrations to respond. Hypocotyls of dwf2 and E-1 elongated equally with applied ent-kaurenol, ent-kaurenoic acid, GA(53)-aldehyde, GA(53), GA(19), GA(20), and GA(1) indicating that the biochemical block in dwf2 occurs at a very early step in the GA-biosynthetic pathway.